We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pergamum Announces Final Data from Phase I/II Study of LL-37

News   Oct 10, 2013

 
Pergamum Announces Final Data from Phase I/II Study of LL-37
 
 
 

RELATED ARTICLES

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Antibody Combo Suppressed HIV Levels in Early Trial

News

In an early trial, a combination of two antibodies suppressed blood levels of HIV for months after treatment in some people.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE